Vaxcyte Inc’s filing revealed that its SVP, GEN COUNSEL & CORP SEC Eydelman Mikhail unloaded Company’s shares for reported $0.46 million on Dec 05 ’24. In the deal valued at $91.49 per share,5,000 shares were sold. As a result of this transaction, Eydelman Mikhail now holds 28,697 shares worth roughly $2.64 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, PICKERING GRANT bought 2,366 shares, generating $221,647 in total proceeds.
Before that, Eydelman Mikhail bought 5,000 shares. Vaxcyte Inc shares valued at $463,750 were divested by the Officer at a price of $92.75 per share.
Mizuho initiated its Vaxcyte Inc [PCVX] rating to a Buy in a research note published on December 07, 2023; the price target was $69. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid April with a ‘”an Outperform”‘ rating. Needham also remained covering PCVX and reiterated its “Buy” recommendation on January 03, 2023. Guggenheim started covering the stock on December 15, 2022. It rated PCVX as “a Buy”.
Price Performance Review of PCVX
On Monday, Vaxcyte Inc [NASDAQ:PCVX] saw its stock fall -1.34% to $92.06. Over the last five days, the stock has gained 0.50%. Vaxcyte Inc shares have risen nearly 46.59% since the year began. Nevertheless, the stocks have risen 62.13% over the past one year. While a 52-week high of $121.06 was reached on 09/19/24, a 52-week low of $53.83 was recorded on 01/05/24. SMA at 50 days reached $103.42, while 200 days put it at $84.08.
Levels Of Support And Resistance For PCVX Stock
The 24-hour chart illustrates a support level at 90.77, which if violated will result in even more drops to 89.47. On the upside, there is a resistance level at 93.98. A further resistance level may holdings at 95.89. The Relative Strength Index (RSI) on the 14-day chart is 43.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.96, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 28.18%. Stochastics %K at 70.52% indicates the stock is a holding.
How much short interest is there in Vaxcyte Inc?
A steep rise in short interest was recorded in Vaxcyte Inc stocks on 2024-11-15, growing by 0.34 million shares to a total of 9.69 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 9.34 million shares. There was a rise of 3.54%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 17, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $69 price target.
